Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fish Oils | 7 | 2019 | 470 | 0.570 |
Why?
|
Parenteral Nutrition | 6 | 2019 | 650 | 0.480 |
Why?
|
Fat Emulsions, Intravenous | 4 | 2019 | 321 | 0.460 |
Why?
|
Thyroid Neoplasms | 6 | 2015 | 2282 | 0.390 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2010 | 111 | 0.380 |
Why?
|
Soybean Oil | 6 | 2019 | 133 | 0.360 |
Why?
|
Pathology, Clinical | 2 | 2016 | 368 | 0.320 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2008 | 25 | 0.320 |
Why?
|
Protective Agents | 2 | 2019 | 156 | 0.310 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2008 | 60 | 0.300 |
Why?
|
Fatty Liver | 5 | 2019 | 727 | 0.290 |
Why?
|
Salivary Gland Neoplasms | 2 | 2022 | 298 | 0.290 |
Why?
|
Fatty Acids, Essential | 3 | 2014 | 95 | 0.230 |
Why?
|
Adenoma | 3 | 2010 | 2174 | 0.230 |
Why?
|
Docosahexaenoic Acids | 4 | 2016 | 875 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 602 | 0.220 |
Why?
|
Awards and Prizes | 1 | 2007 | 375 | 0.210 |
Why?
|
Ki-67 Antigen | 3 | 2016 | 644 | 0.200 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 88 | 0.200 |
Why?
|
Arachidonic Acid | 2 | 2012 | 434 | 0.190 |
Why?
|
Endocrinology | 1 | 2007 | 443 | 0.180 |
Why?
|
alpha-Tocopherol | 1 | 2019 | 127 | 0.170 |
Why?
|
Pituitary Neoplasms | 3 | 2014 | 1345 | 0.160 |
Why?
|
Paraganglioma | 2 | 2009 | 143 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.140 |
Why?
|
PPAR gamma | 1 | 2019 | 493 | 0.130 |
Why?
|
Genes, p16 | 1 | 2015 | 157 | 0.130 |
Why?
|
Hydroxamic Acids | 2 | 2010 | 494 | 0.130 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.130 |
Why?
|
Disease Models, Animal | 12 | 2019 | 18029 | 0.130 |
Why?
|
Pyrvinium Compounds | 1 | 2014 | 4 | 0.130 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 21827 | 0.120 |
Why?
|
Endotoxemia | 1 | 2016 | 207 | 0.120 |
Why?
|
Hypoglycemia | 2 | 2016 | 861 | 0.120 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 162 | 0.120 |
Why?
|
Pituitary Gland, Anterior | 1 | 2014 | 177 | 0.120 |
Why?
|
Adrenal Cortex | 1 | 2014 | 140 | 0.120 |
Why?
|
Immunohistochemistry | 9 | 2017 | 11366 | 0.120 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2010 | 324 | 0.120 |
Why?
|
Hemangiosarcoma | 1 | 2015 | 239 | 0.110 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 226 | 0.110 |
Why?
|
In Situ Hybridization | 1 | 2017 | 1950 | 0.110 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2014 | 224 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2016 | 3200 | 0.100 |
Why?
|
Sulfonamides | 2 | 2015 | 1938 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1222 | 0.100 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2012 | 126 | 0.100 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2012 | 177 | 0.100 |
Why?
|
Lipopolysaccharides | 2 | 2016 | 2216 | 0.100 |
Why?
|
Gene Dosage | 1 | 2015 | 1252 | 0.100 |
Why?
|
Hypocalcemia | 1 | 2012 | 191 | 0.100 |
Why?
|
Carcinoma | 2 | 2015 | 2375 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2017 | 1119 | 0.090 |
Why?
|
Bone Development | 1 | 2014 | 483 | 0.090 |
Why?
|
Dietary Supplements | 2 | 2014 | 3297 | 0.090 |
Why?
|
Thioglycosides | 1 | 2009 | 3 | 0.090 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.090 |
Why?
|
Triglycerides | 2 | 2016 | 2454 | 0.090 |
Why?
|
Parathyroidectomy | 1 | 2012 | 235 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 740 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2022 | 1581 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 545 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 546 | 0.090 |
Why?
|
Liver Diseases | 1 | 2017 | 1253 | 0.080 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2009 | 46 | 0.080 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2008 | 51 | 0.080 |
Why?
|
Liver Failure | 1 | 2011 | 241 | 0.080 |
Why?
|
Carcinoma, Papillary | 2 | 2015 | 783 | 0.080 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2008 | 46 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2902 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 417 | 0.080 |
Why?
|
Chromogranin A | 1 | 2008 | 54 | 0.080 |
Why?
|
Cholestasis | 1 | 2011 | 378 | 0.080 |
Why?
|
Galectin 3 | 1 | 2009 | 227 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2043 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1420 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2016 | 1344 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2009 | 358 | 0.080 |
Why?
|
Phospholipids | 1 | 2011 | 784 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.070 |
Why?
|
Hepatitis | 1 | 2008 | 227 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4420 | 0.070 |
Why?
|
Calcitonin | 1 | 2008 | 336 | 0.070 |
Why?
|
Societies | 1 | 2007 | 104 | 0.070 |
Why?
|
Keratins | 1 | 2008 | 515 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 791 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 906 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2635 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2009 | 374 | 0.070 |
Why?
|
Achievement | 1 | 2007 | 291 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1587 | 0.060 |
Why?
|
PPAR alpha | 1 | 2006 | 197 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.060 |
Why?
|
Thyrotropin | 1 | 2008 | 849 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.060 |
Why?
|
Animals | 20 | 2019 | 168757 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2015 | 2969 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12959 | 0.060 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 371 | 0.060 |
Why?
|
Thyroid Nodule | 1 | 2010 | 750 | 0.060 |
Why?
|
Mice | 14 | 2019 | 81183 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1026 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5172 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2734 | 0.050 |
Why?
|
Emulsions | 2 | 2014 | 156 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4034 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 1947 | 0.050 |
Why?
|
Hepatocytes | 1 | 2008 | 1211 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13695 | 0.050 |
Why?
|
Intestinal Obstruction | 1 | 2005 | 424 | 0.050 |
Why?
|
Male | 23 | 2019 | 350118 | 0.050 |
Why?
|
Bone Density | 1 | 2014 | 3468 | 0.050 |
Why?
|
Eicosapentaenoic Acid | 2 | 2016 | 582 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2008 | 1173 | 0.050 |
Why?
|
Blood Vessels | 1 | 2006 | 1125 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 2 | 2015 | 643 | 0.050 |
Why?
|
History, 21st Century | 1 | 2007 | 1534 | 0.050 |
Why?
|
Cell Movement | 1 | 2012 | 5217 | 0.040 |
Why?
|
Pneumonectomy | 1 | 2006 | 1094 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2005 | 763 | 0.040 |
Why?
|
Phytosterols | 1 | 2019 | 64 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2005 | 1352 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 86 | 0.040 |
Why?
|
History, 20th Century | 1 | 2007 | 2740 | 0.040 |
Why?
|
Middle Aged | 12 | 2019 | 213383 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.040 |
Why?
|
Adult | 12 | 2019 | 214055 | 0.040 |
Why?
|
DNA Probes, HPV | 1 | 2017 | 21 | 0.040 |
Why?
|
RNA Probes | 1 | 2017 | 113 | 0.040 |
Why?
|
Fixatives | 1 | 2017 | 94 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2008 | 2585 | 0.040 |
Why?
|
Liver | 4 | 2016 | 7474 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2005 | 812 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2017 | 101 | 0.040 |
Why?
|
Humans | 23 | 2022 | 744343 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2017 | 299 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 809 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5686 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2006 | 3508 | 0.030 |
Why?
|
Formaldehyde | 1 | 2017 | 353 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5179 | 0.030 |
Why?
|
Female | 15 | 2019 | 380194 | 0.030 |
Why?
|
Aged | 9 | 2019 | 163280 | 0.030 |
Why?
|
Pyrazoles | 1 | 2005 | 1972 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 2649 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5882 | 0.030 |
Why?
|
Postprandial Period | 1 | 2016 | 292 | 0.030 |
Why?
|
Transcription Factors | 3 | 2022 | 12208 | 0.030 |
Why?
|
Deficiency Diseases | 1 | 2014 | 72 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.030 |
Why?
|
Apoptosis | 4 | 2015 | 9727 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 4456 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7186 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3305 | 0.030 |
Why?
|
Lung | 2 | 2016 | 9856 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 2014 | 302 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 408 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2014 | 229 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2924 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2014 | 1095 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2014 | 428 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.030 |
Why?
|
Dietary Fats | 2 | 2012 | 2017 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1878 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 402 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1850 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5853 | 0.020 |
Why?
|
Plant Oils | 1 | 2011 | 202 | 0.020 |
Why?
|
Insulin | 1 | 2005 | 6580 | 0.020 |
Why?
|
Growth | 1 | 2012 | 376 | 0.020 |
Why?
|
Weight Gain | 2 | 2014 | 2292 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2716 | 0.020 |
Why?
|
Thiogalactosides | 1 | 2009 | 7 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 320 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2362 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2593 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15295 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2012 | 546 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1791 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2017 | 63114 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2016 | 1431 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1682 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11524 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 110 | 0.020 |
Why?
|
Common Bile Duct | 1 | 2008 | 109 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3870 | 0.020 |
Why?
|
3-Iodobenzylguanidine | 1 | 2009 | 115 | 0.020 |
Why?
|
Infant | 2 | 2008 | 35136 | 0.020 |
Why?
|
Biliary Atresia | 1 | 2008 | 73 | 0.020 |
Why?
|
Osteoblasts | 1 | 2014 | 1166 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 216 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 453 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 472 | 0.020 |
Why?
|
Child, Preschool | 2 | 2008 | 41006 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2839 | 0.020 |
Why?
|
Drug Approval | 1 | 2014 | 742 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 440 | 0.020 |
Why?
|
Femur | 1 | 2014 | 1297 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2008 | 248 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2010 | 665 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1012 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5892 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
Food, Fortified | 1 | 2008 | 191 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2008 | 647 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 1788 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 758 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2009 | 486 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2009 | 280 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 638 | 0.020 |
Why?
|
Prolactin | 1 | 2008 | 669 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2012 | 804 | 0.020 |
Why?
|
Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3128 | 0.020 |
Why?
|
Diazoxide | 1 | 2005 | 57 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2019 | 77449 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10943 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1170 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4186 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3493 | 0.020 |
Why?
|
Drug Synergism | 1 | 2009 | 1792 | 0.020 |
Why?
|
Molecular Structure | 1 | 2009 | 1899 | 0.020 |
Why?
|
Octreotide | 1 | 2005 | 145 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4851 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2564 | 0.020 |
Why?
|
Young Adult | 3 | 2017 | 56430 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9648 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2006 | 599 | 0.020 |
Why?
|
Diet Therapy | 1 | 2005 | 154 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16689 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1919 | 0.020 |
Why?
|
Necrosis | 1 | 2008 | 1643 | 0.020 |
Why?
|
Endothelial Growth Factors | 1 | 2006 | 694 | 0.010 |
Why?
|
Tissue Adhesions | 1 | 2005 | 235 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14557 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2148 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2004 | 367 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1799 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2889 | 0.010 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2004 | 373 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 20947 | 0.010 |
Why?
|
Doxorubicin | 1 | 2009 | 2234 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3327 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4204 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2004 | 657 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2016 | 3864 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.010 |
Why?
|
Hyperplasia | 1 | 2005 | 1185 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9734 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57776 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
Zebrafish | 1 | 2012 | 2994 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2005 | 804 | 0.010 |
Why?
|
Random Allocation | 1 | 2005 | 2429 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13815 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2008 | 895 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1641 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2014 | 25625 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9386 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2505 | 0.010 |
Why?
|
Aneuploidy | 1 | 2003 | 530 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2886 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1351 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18111 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
Child | 3 | 2016 | 77709 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 85781 | 0.010 |
Why?
|
Pancreas | 1 | 2005 | 1686 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1863 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4982 | 0.010 |
Why?
|
Regeneration | 1 | 2006 | 1485 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2003 | 1179 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2009 | 35421 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 19229 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5102 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 21683 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3507 | 0.010 |
Why?
|
Diet | 1 | 2012 | 7939 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.010 |
Why?
|
Rats | 1 | 2009 | 24260 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3462 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6234 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15540 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10481 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39050 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 12788 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14722 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2003 | 11031 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20129 | 0.000 |
Why?
|